|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/47 | (2006.01) |
| A61K 31/337 | (2006.01) | ||
| C12N 9/26 | (2006.01) | ||
| A61K 38/43 | (2006.01) |
| (11) | Number of the document | 3130347 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16189970.3 |
| Date of filing the European patent application | 2012-12-28 | |
| (97) | Date of publication of the European application | 2017-02-15 |
| (45) | Date of publication and mention of the grant of the patent | 2019-09-18 |
| (46) | Date of publication of the claims translation | 2019-10-25 |
| (30) | Number | Date | Country code |
| 201161631313 P | 2011-12-30 | US | |
| 201261796208 P | 2012-11-01 | US |
| (72) |
WEI, Ge, US
SHEPARD, H., Michael, US
ZHAO, Qiping, US
CONNOR, Robert James, US
|
| (73) |
Halozyme, Inc.,
11388 Sorrento Valley Road, San Diego, CA 92121,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | PH20 polipeptido variantai, kompozicijos ir jų panaudojimas |
| PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-12-31 | 14 | 433.50 EUR |
| 2026-12-28 |